Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Anti-Hep B Antibodies and Immune Memory Challenge in Children
NCT02697474Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Sanofi. Primary endpoint: Levels of anti-Hepatitis B antibody concentrations at Day 0. Started Feb 2016; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02697474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697474.